Isotretinoin
Retinoid which is a synthetic derivative of vitamin A. It is a cis-configuration of Tretinoin, an acid form of vitamin A.
Indicated in the treatment of severe forms of acne.
At latest update no published data on excretion into breast milk were found.
Despite of a high plasma protein-binding capacity, it is a highly lipophilic substance, hence, it is presumed to accumulate in breastmilk. The natural form of vitamin A is readily excreted into breastmilk.
In addition to being a potent teratogen (Shirazi 2015), which affects pregnancy, it has been shown to decrease all pituitary hormones levels (Karadag 2011 and 2015) along with other potential serious side effects associated to the use of Isotretinoin. It may cause galactorrhea (Larsen 1985).
A safer alternative should be preferred until more published data on this drug related to breastfeeding is available, especially during the neonatal period and in case of prematurity.
Alternatives
- Adapalene (Very Low Risk)
- Azelaic Acid (Very Low Risk)
- Benzoyl Peroxide (Very Low Risk)
- Ethinylestradiol + Norethindrone (Low Risk probable)
- Tretinoin (topical use) (Very Low Risk)
Very Low Risk
Compatible. Not risky for breastfeeding or infant.
Low Risk
Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.
High Risk
Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.
Very High Risk
Not recommended. Cessation of breastfeeding or alternative.
Synonyms
- 13-Cis-Retinoic Acid
Writings
- Ισοτρετινοΐνη (Greek)
- إيزوتريتينوئين (Arabic)
- Изотретиноин (Cyrillic)
- 异维A酸 (Chinese)
- イソトレチノイン (Japanese)
- C20H28O2 (Molecular formula)
Drug trade names
References
- Karadag AS, Takci Z, Ertugrul DT, Bilgili SG, Balahoroglu R, Takir M. The effect of different doses of isotretinoin on pituitary hormones. Dermatology. 2015Abstract
- Shirazi M, Abbariki E, Pirjani R, Akhavan S, Dastgerdy E. Congenital microtia in a neonate due to maternal isotretinoin exposure 1 month before pregnancy: Case Report. J Obstet Gynaecol Res. 2015Abstract
- Butler DC, Heller MM, Murase JE. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation. J Am Acad Dermatol. 2014Abstract
- Bayerl C. [Acne therapy in pregnancy]. Hautarzt. 2013Abstract
- Karadag AS, Ertugrul DT, Tutal E, Akin KO. Isotretinoin influences pituitary hormone levels in acne patients. Acta Derm Venereol. 2011Abstract
- Larsen GK. Iatrogenic breast discharge with isotretinoin. Arch Dermatol. 1985Abstract